Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Filing Meeting Email, February 7, 2012 - Octaplas


From:                    Peng, Ze
Sent:                      Tuesday, February 07, 2012 3:24 PM
To:                         Rana, Pratibha; Kirschbaum, Nancy
Cc:                         Lee, Timothy
Subject:                 RE: Filing Meeting/STN 125416/0/OctaplastLG from Octapharma
Good afternoon, Pratibha and Nancy:
Regarding the original BLA under STN 125416 submitted by Octapharma for Solvent/Detergent treatment human plasma, OctaplasLG, I did a preliminary review on two sections, Stability (3.2.S.7 and 3.2.P.8) and Adventitious Agents Safety Evaluation (3.2.A.2). I found that the information provided in these sections will allow me to perform a meaningful review. Therefore, this submission can be filed.

Page Last Updated: 02/15/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English